Consensus Cloud Solutions (CCSI) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 consolidated revenue grew 0.3% year-over-year to $87.7 million, marking the first increase in eight quarters, driven by a 6.9% rise in Corporate revenue and a planned 9.4% decline in SoHo revenue.
Adjusted EBITDA was $48.1 million, down 2.1% year-over-year, with a margin of 54.8%, near the top end of guidance.
Adjusted net income increased 3.2% to $28.4 million; adjusted EPS rose 2.1% to $1.46, benefiting from favorable net interest and lower depreciation/amortization.
Net income for Q2 2025 was $20.8 million, down from $23.9 million in Q2 2024; net income margin was 23.7%.
Secured a $225 million credit facility post-quarter to refinance 6% senior notes due October 2026.
Financial highlights
Q2 2025 revenue: $87.7 million; adjusted EBITDA: $48.1 million (54.8% margin); adjusted net income: $28.4 million; adjusted EPS: $1.46.
Free cash flow: $20.3 million, up 28.7% year-over-year; capex: $7.9 million, down 7%.
Gross profit: $70.1 million (80% margin); operating income: $39.0 million.
Cash and equivalents at quarter-end: $57.9 million.
Q2 2025 equity repurchases: 546,000 shares for ~$12 million; bond repurchases: ~$6 million face value.
Outlook and guidance
Full-year 2025 revenue guidance reaffirmed at $343–$357 million; adjusted EBITDA at $179–$190 million; adjusted EPS guidance raised to $5.25–$5.65.
Q3 2025 guidance: revenue $85.9–$89.9 million, adjusted EBITDA $44.4–$47.4 million, adjusted EPS $1.33–$1.42.
2025 free cash flow expected to exceed $85 million.
Management expects organic and inorganic growth, with capital allocated to reinvestment and acquisitions in interoperability.
Existing cash, cash flow, and financing expected to cover needs for at least 12 months.
Latest events from Consensus Cloud Solutions
- Corporate growth, record cash flow, and debt reduction drive a strong 2026 outlook.CCSI
Q4 202510 Feb 2026 - Healthcare solutions and recurring revenue drive growth as FY2024 guidance is reaffirmed.CCSI
Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - Net income and margins rose in Q2 2024 despite lower revenue, with improved guidance for the year.CCSI
Q2 20241 Feb 2026 - Healthcare interoperability, AI, and capital returns drive growth and margin improvement.CCSI
Jefferies Global Healthcare Conference31 Jan 2026 - Q3 revenue fell 3.1% but margin gains and debt reduction supported strong corporate growth.CCSI
Q3 202415 Jan 2026 - Record free cash flow, margin strength, and debt reduction highlight 2024 performance.CCSI
Q4 202423 Dec 2025 - Proxy covers director elections, auditor ratification, pay, ESG, and strong governance.CCSI
Proxy Filing2 Dec 2025 - Virtual meeting to vote on directors, auditor, and executive pay, all board-recommended.CCSI
Proxy Filing2 Dec 2025 - Q1 2025 revenue down 1.1%, Corporate growth offsets SoHo decline; guidance reaffirmed.CCSI
Q1 202525 Nov 2025